Your browser is no longer supported. Please, upgrade your browser.
AGN Allergan plc weekly Stock Chart
Allergan plc
IndexS&P 500 P/E- EPS (ttm)-25.60 Insider Own0.30% Shs Outstand327.80M Perf Week2.78%
Market Cap56.55B Forward P/E10.19 EPS next Y16.94 Insider Trans0.00% Shs Float327.17M Perf Month3.92%
Income-8519.10M PEG- EPS next Q4.22 Inst Own89.10% Short Float3.16% Perf Quarter5.72%
Sales15.68B P/S3.61 EPS this Y24.90% Inst Trans-1.18% Short Ratio3.09 Perf Half Y22.94%
Book/sh182.05 P/B0.95 EPS next Y1.24% ROA-8.50% Target Price183.64 Perf Year-8.24%
Cash/sh6.02 P/C28.65 EPS next 5Y3.70% ROE-13.20% 52W Range114.27 - 192.69 Perf YTD29.06%
Dividend2.96 P/FCF13.11 EPS past 5Y-36.00% ROI-4.80% 52W High-10.48% Beta1.64
Dividend %1.72% Quick Ratio0.90 Sales past 5Y43.40% Gross Margin85.10% 52W Low50.96% ATR1.62
Employees16900 Current Ratio1.00 Sales Q/Q-0.80% Oper. Margin-54.60% RSI (14)73.08 Volatility0.94% 0.94%
OptionableYes Debt/Eq0.38 EPS Q/Q-285.10% Profit Margin-54.20% Rel Volume0.87 Prev Close170.92
ShortableYes LT Debt/Eq0.33 EarningsNov 05 BMO Payout- Avg Volume3.35M Price172.50
Recom2.70 SMA202.94% SMA505.31% SMA20014.96% Volume2,905,099 Change0.92%
Aug-07-19Downgrade Guggenheim Buy → Neutral
Jul-18-19Downgrade SVB Leerink Outperform → Mkt Perform
Jul-16-19Downgrade Bernstein Outperform → Mkt Perform
Jun-11-19Initiated Barclays Underweight $133
May-28-19Initiated Goldman Neutral
Apr-15-19Initiated Jefferies Hold
Mar-20-19Initiated SunTrust Buy $178
Jan-31-19Downgrade Credit Suisse Outperform → Neutral
Jan-30-19Downgrade RBC Capital Mkts Outperform → Sector Perform
Jan-30-19Downgrade Morgan Stanley Overweight → Equal-Weight
Oct-09-18Resumed Guggenheim Buy
Apr-24-18Resumed Citigroup Buy $200
Apr-23-18Resumed Evercore ISI Outperform
Apr-17-18Initiated Stifel Hold $192
Feb-23-18Initiated SunTrust Buy $200
Feb-07-18Reiterated Leerink Partners Outperform $237 → $242
Dec-07-17Downgrade Argus Buy → Hold
Nov-29-17Upgrade Morgan Stanley Equal-Weight → Overweight
Nov-27-17Resumed Leerink Partners Outperform $237
Nov-02-17Reiterated RBC Capital Mkts Outperform $250 → $221
Oct-17-19 07:00AM  Allergan to Report Third Quarter 2019 Financial Results PR Newswire
Oct-16-19 12:16PM  Editas Inks Deal for Gene Editing Neurological Disease Drugs Zacks
12:02PM  'High-level dope dealers': Democratic candidates sound off on big pharma Yahoo Finance
Oct-15-19 05:04PM  Allergan (AGN) Shareholders Approve Acquisition by AbbVie Zacks
Oct-14-19 07:04PM  Johnson & Johnson's (JNJ) Legal Problems Continue to Worry Investors Zacks
10:28AM  Aclaris Divests Rhofade to EPI Health for $55M, Shares Up Zacks
09:15AM  Allergan Shareholders Approve Proposed Acquisition by AbbVie PR Newswire
Oct-11-19 07:40PM  Allergan and Molecular Partners Present Late-Breaking Data from Phase 3 Studies of Investigational Abicipar pegol in Neovascular Wet Age-Related Macular Degeneration PR Newswire
Oct-10-19 10:11AM  Wet AMD Space in Focus: New Drug Approvals & Key Advancements Zacks
07:30AM  On World Sight Day, Allergan Launches National Campaign to Raise Awareness of the Toll Glaucoma Takes on Everyday Living PR Newswire
Oct-07-19 07:30AM  Allergan Expands REFRESH® Portfolio With New REFRESH® RELIEVA Lubricant Eye Drop Product Line PR Newswire
Oct-03-19 05:30PM  Here Is Hedge Funds 22nd Most Popular Stock Pick Insider Monkey
04:17PM  Here Are 3 Notable Pharma Stocks That Could Top Third-Quarter Estimates Investor's Business Daily
12:14PM  INVESTOR ALERT: Monteverde & Associates PC Announces an Investigation of the Following Merger PR Newswire
11:16AM  J&J Settles Ahead of Multi-District Opioid Trial, Stock Up Zacks
09:00AM  AbbVie Stock Is Poised To Become A Top 5 Pharma But Should You Buy It? Investor's Business Daily
07:30AM  Allergan to Showcase Late-Stage Data in Age-Related Macular Degeneration and Glaucoma at American Academy of Ophthalmology Annual Meeting PR Newswire
Oct-02-19 04:21PM  Pharma Giant J&J Avoids Opioid Trial In Ohio With $20.4 Million Payout Investor's Business Daily
Oct-01-19 05:50PM  Allergan (AGN) Stock Moves -1.09%: What You Should Know Zacks
05:02PM  Opioid makers, distributors face shaky future as legal woes mount Yahoo Finance
Sep-30-19 07:22AM  5 Most Shorted Sectors in 2019 Investopedia
Sep-27-19 05:33PM  IntelGenx (IGXT) Resubmits NDA for Migraine Candidate to FDA Zacks
04:57PM  FTC requests AbbVie, Allergan for more information on $63 billion deal Reuters
04:16PM  Allergan and AbbVie Receive Second Request from Federal Trade Commission on Pending Transaction PR Newswire
04:15PM  AbbVie and Allergan Receive Second Request from Federal Trade Commission on Pending Transaction PR Newswire
Sep-26-19 01:46PM  Citi Bullish On AbbVie As Allergan Deal Provides An Earnings Floor Benzinga
11:30AM  ALLERGAN MERGER INVESTIGATION: Halper Sadeh LLP Announces Investigation into Whether the Sale of Allergan PLC is Fair to Shareholders; Investors are Encouraged to Contact the Firm - AGN ACCESSWIRE
08:45AM  AbbVie Is Up After Another Analyst Reconsidered Its Allergan Acquisition and Upgraded the Stock
Sep-24-19 05:50PM  Allergan (AGN) Stock Moves -0.1%: What You Should Know Zacks
02:54PM  3 Stocks Thriving on Competitors' Failures
10:12AM  The Zacks Analyst Blog Highlights: Bristol-Myers, Lockheed, Alphabet, Allergan and Kinder Morgan Zacks
10:02AM  Fast-growing Atlanta biomedical company hires new CEO American City Business Journals
Sep-23-19 02:28PM  Top Analyst Reports for Bristol-Myers Squibb, Lockheed Martin & Alphabet Zacks
01:19PM  SHAREHOLDER INVESTIGATION ALERT: Halper Sadeh LLP Continues to Investigate Whether the Sale of These Companies Is Fair to Shareholders AGN, ORIT, MCRN, GHDX GlobeNewswire
01:09PM  Fast-growing Atlanta biomedical company hires new CEO American City Business Journals
03:37AM  FDA Warns About Safety of Breast Implant: 3 Stocks at Risk (Revised) Zacks
Sep-19-19 02:31PM  Ironwood Amends Linzess Agreement with AstraZeneca in China Zacks
11:15AM  11 Most Aggressively Shorted Stocks Benzinga
09:31AM  FDA Warns About Safety of Breast Implant: 3 Stocks at Risk Zacks
03:20AM  5 Undervalued Stocks to Buy InvestorPlace
Sep-18-19 12:27PM  Establishment Labs Poised to Capitalize on Allergan Breast Implant Issues
Sep-17-19 04:15PM  Announcement under the Irish Takeover Rules: Relevant Securities in Issue - September 17, 2019 PR Newswire
03:30PM  Could Algernon Pharmaceuticals Inc.'s (CNSX:AGN) Investor Composition Influence The Stock Price? Simply Wall St.
07:30AM  Allergan Announces Commencement of Mailing of Proxy Statement PR Newswire
Sep-16-19 05:50PM  Allergan (AGN) Dips More Than Broader Markets: What You Should Know Zacks
09:01AM  AbbVie Inc. -- Moody's assigns Baa2 to AbbVie's euro notes; stable outlook Moody's
Sep-13-19 11:08AM  Ardelyx Gets FDA Approval for Ibsrela As IBS-C Treatment Zacks
09:46AM  Pharma Stock Roundup: Pipeline/Regulatory Updates From GSK, PFE & Others Zacks
Sep-12-19 07:25PM  Seth Klarman's Favorite Health Care Stocks
06:22PM  Consumer groups, unions urge caution on $63 billion AbbVie deal for Allergan Reuters
06:11PM  Consumer groups, unions urge caution on $63 bln AbbVie deal for Allergan Reuters
04:09PM  Humira Sales Will Crash To $3 Billion Why AbbVie Stock Got An Upgrade Investor's Business Daily
11:47AM  Buy AbbVie Stock, Because Its Deal for Allergan Just Might Work, Analyst Says
Sep-11-19 06:01AM  Allergan's Filings for Abicipar Pegol Accepted in U.S/Europe Zacks
Sep-10-19 05:45PM  Allergan (AGN) Outpaces Stock Market Gains: What You Should Know Zacks
04:36PM  Allergan Shareholder Meetings Scheduled for October 14, 2019 PR Newswire
Sep-09-19 11:33AM  The Zacks Analyst Blog Highlights: Allergan, Merck, Roche, J&J and Bristol-Myers Zacks
09:19AM  U.S. judge denies bid to dismiss claim opioids are a public nuisance Reuters
07:30AM  Allergan and Molecular Partners Announce Acceptance of U.S. FDA Biologics License Application and Validation of EMA Marketing Authorisation for Abicipar pegol in Patients with Neovascular (Wet) Age-related Macular Degeneration PR Newswire
Sep-06-19 03:07PM  ETFs Poised to Benefit from Gene Editing Revolution Zacks
01:29PM  UPDATE 1-Mallinckrodt to pay $24 mln in cash to settle opioid lawsuits with two Ohio counties Reuters
11:36AM  Pharma Stock Roundup: AGN's Opioid Settlement, Line Extension Nod in EU for MRK, JNJ Drugs Zacks
Sep-05-19 04:51PM  3 Special Situations Gurus Are Buying
10:35AM  Endo Gains FDA Nod for Orfadin Generic to Treat Rare Disease Zacks
09:31AM  Allergan (AGN) Up 1.8% Since Last Earnings Report: Can It Continue? Zacks
03:10AM  [video]Mallinckrodt Plunges on Report It's Considering Filing for Bankruptcy
Sep-04-19 05:50PM  Allergan (AGN) Outpaces Stock Market Gains: What You Should Know Zacks
04:22PM  Why The Opioid Epidemic Just Got More Complicated For Generic Pharmas Investor's Business Daily
10:31AM  Ardelyx (ARDX) Gains on Tenapanor's Success in Pivotal Study Zacks
Sep-03-19 07:30AM  Allergan Receives FDA Approval of Juvéderm VOLUMA® XC For Mid-Face Injection Via Cannula PR Newswire
Sep-02-19 09:41AM  Allergan Settles Ahead of Multi-District Opioid Litigation Zacks
Aug-30-19 10:03AM  Allergan Settles to Get Out Of First Big Opioid Trial
09:57AM  Its Not All Bad News for Generic-Drug Companies. Sales Rose in July.
08:00AM  Will Opioid Litigation Take its Toll on Pharma Companies? Zacks
07:09AM  Allergan settles with 2 Ohio plaintiffs in federal opioid litigation MarketWatch
07:00AM  Allergan Announces Settlement with Two Ohio Plaintiffs in Federal Opioid Litigation PR Newswire
05:39AM  [video]Allergan Reaches Settlement With Ohio Plaintiffs in Federal Opioid Litigation
Aug-28-19 04:29PM  What Purdue's Rumored Deal Means For Other Opioid-Tied Pharmas Investor's Business Daily
Aug-27-19 02:03PM  Should You Buy AbbVie for the Dividend? Motley Fool
11:01AM  J&J Up Despite $572M Fine in Oklahoma Opioid Abuse Case Zacks
Aug-23-19 10:36AM  Amgen Presents Positive Data From Rituxan Biosimilar Study Zacks
10:15AM  J&J's (JNJ) Opioid Lawsuit Verdict in Oklahoma Due Next Week Zacks
04:59AM  Hedge Funds Pile Into Health Care Investopedia
Aug-22-19 09:00AM  Amgen And Allergan Announce Positive Top-Line Results From Comparative Clinical Study Of ABP 798, Biosimilar Candidate To Rituxan® (Rituximab) PR Newswire
Aug-21-19 04:15PM  Opioid Epidemic: Will Pharmas Scramble To Settle As Landmark Case Looms? Investor's Business Daily
01:38PM  Endo Up on Settlement of a Few Cases Related to Opioid Drugs Zacks
01:11PM  Goldman Warns Hedge Fund Outperformance Holds Crowding Risk Bloomberg
07:15AM  AbbVie Stock Slipped to a New Low, and One Exec Scooped Up Shares
Aug-20-19 12:20PM  Endo, Allergan could avoid trial with opioid settlements Yahoo Finance Video
11:06AM  Buy AbbVie Stock Because You Cant Ignore How Cheap It Is
10:15AM  Endo, Allergan could avoid trial with Ohio over opioid crisis Yahoo Finance Video
09:44AM  Here's Why Allergan is Outperforming Its Industry Of Late Zacks
06:43AM  Endo Surges as Opioid Maker Reaches Settlement in Landmark Lawsuit
03:23AM  [video]Endo, Allergan Nearing Deals to Limit Ohio Litigation Over Opioids - Report
Aug-19-19 02:45PM  Obesity Epidemic Leads To A New Problem And It Could Be Worth Billions Investor's Business Daily
Aug-15-19 12:50PM  Seth Klarman's Baupost Boosts Liberty, Reduces eBay
Aug-14-19 07:59AM  Correction: Allergan sale Financial Times
12:00AM  Elliott bags Goldmans Barg Financial Times
Aug-13-19 10:59AM  Implied Volatility Surging for Allergan (AGN) Stock Options Zacks
10:48AM  Here's Why Amgen Stock is Outperforming Its Industry Of Late Zacks
Allergan plc, a pharmaceutical company, develops, manufactures, and commercializes branded pharmaceutical, device, biologic, surgical, and regenerative medicine products worldwide. The company operates in three segments: US Specialized Therapeutics, US General Medicine, and International. It offers a portfolio of products in various therapeutic areas, including medical aesthetics and dermatology, eye care, neuroscience, urology, gastrointestinal, women's health, and anti-infective therapeutic products. The company also offers breast implants and tissue expanders; and RM-131 (relamorelin), a peptide ghrelin agonist for the treatment of diabetic gastroparesis. In addition, it develops medical and cosmetic treatments; therapies for non-alcoholic steatohepatitis and other liver diseases; inhibitor for the treatment of psoriasis and other autoimmune disorders; atopic dermatitis drug candidate; peri-ocular rings for extended drug delivery and reducing elevated intraocular pressure in glaucoma patients; and treatments for neurodegenerative disorders, including Alzheimer's disease. Further, the company develops RST-001, a novel gene therapy for the treatment of retinitis pigmentosa; small molecule therapeutics for inflammatory and fibrotic diseases; topical medicines for fat reduction; and delivery system and botulinum toxin-based prescription products. It has a collaboration, option, and license agreement with Lyndra, Inc.; strategic alliance and option agreement with Editas Medicine, Inc.; and gene therapy research collaboration with The National Institute for Bioprocessing Research and Training. Allergan plc also has licensing agreements with Assembly Biosciences, Inc.; MedImmune; and Heptares Therapeutics, Ltd. The company was formerly known as Actavis plc and changed its name to Allergan plc in June 2015. Allergan plc was founded in 1983 and is headquartered in Dublin, Ireland.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
SAUNDERS BRENT LChairman, President and CEOMar 07Buy143.671,760252,858170,666Mar 07 03:19 PM
WALSH MATTHEW MEVP, Chief Financial OfficerNov 16Buy157.001,000157,00026,416Nov 19 07:22 PM